ACR: Bimekizumab Demonstrates Superior Results to Risankizumab in Psoriatic Arthritis

A higher response was seen as early as week 4, and the superiority persisted to week 24
vial
Adobe Stock
Medically Reviewed By:
Farrokh Sohrabi, M.D.
Published on: 
Updated on: 
Loading content, please wait...